metformin has been researched along with Leukemia, Megakaryocytic in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"Metformin has received increasing attention for its potential anticancer activity against certain human leukemia cells, but its effects on human megakaryoblastic cells are unclear." | 1.46 | Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells. ( Gao, C; Guo, G; Kong, P; Liang, X; Wang, J; Xu, Y, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, X | 1 |
Kong, P | 1 |
Wang, J | 1 |
Xu, Y | 1 |
Gao, C | 1 |
Guo, G | 1 |
1 other study available for metformin and Leukemia, Megakaryocytic
Article | Year |
---|---|
Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells.
Topics: Apoptosis; Cell Line; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Humans; | 2017 |